Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ARDMQ NASDAQ:NDRA NASDAQ:TTOO NYSEAMERICAN:VTAK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDMQAradigm$0.05$0.05$0.02▼$0.20$764KN/A21,923 shsN/ANDRAENDRA Life Sciences$8.84+6.5%$3.91$2.90▼$170.63$6.13M-0.18531,777 shs1.92 million shsTTOOT2 Biosystems$0.13-5.8%$0.15$0.06▼$6.00$2.64M0.43581,672 shs140,834 shsVTAKCatheter Precision$0.24-3.4%$0.27$0.16▼$4.76$2.69M-0.724.53 million shs535,777 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDMQAradigm0.00%0.00%0.00%0.00%0.00%NDRAENDRA Life Sciences+139.88%+143.40%+147.02%+63.39%-99.90%TTOOT2 Biosystems-1.33%-3.83%-11.20%+11.00%-97.27%VTAKCatheter Precision+2.99%+5.26%+15.40%-18.51%-93.10%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARDMQAradigmN/AN/AN/AN/AN/AN/AN/AN/ANDRAENDRA Life Sciences2.3616 of 5 stars3.55.00.00.00.60.00.6TTOOT2 Biosystems2.4122 of 5 stars3.05.00.00.00.00.00.0VTAKCatheter Precision0.345 of 5 stars0.02.00.00.01.10.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDMQAradigm 0.00N/AN/AN/ANDRAENDRA Life Sciences 3.00Buy$50.00465.61% UpsideTTOOT2 Biosystems 2.00Hold$5.003,884.06% UpsideVTAKCatheter Precision 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ARDMQ, TTOO, VTAK, and NDRA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2025NDRAENDRA Life SciencesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$75.00 ➝ $50.00(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDMQAradigmN/AN/AN/AN/AN/AN/ANDRAENDRA Life SciencesN/AN/AN/AN/A$4.77 per shareN/ATTOOT2 Biosystems$7.68M0.34N/AN/A($6.91) per share-0.02VTAKCatheter Precision$420K6.19N/AN/A$1.33 per share0.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDMQAradigmN/AN/A0.00∞N/AN/AN/AN/AN/ANDRAENDRA Life Sciences-$11.51M-$172.040.00N/AN/AN/A-140.96%-106.14%8/13/2025 (Estimated)TTOOT2 Biosystems-$50.08MN/A0.00∞N/A-563.16%N/A-174.06%7/28/2025 (Estimated)VTAKCatheter Precision-$16.64MN/A0.00N/AN/A-3,744.91%-153.90%-68.25%8/13/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARDMQAradigmN/AN/AN/AN/AN/ANDRAENDRA Life SciencesN/AN/AN/AN/AN/ATTOOT2 BiosystemsN/AN/AN/AN/AN/AVTAKCatheter PrecisionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDMQAradigmN/AN/AN/ANDRAENDRA Life SciencesN/A3.853.85TTOOT2 BiosystemsN/A0.400.24VTAKCatheter PrecisionN/A0.210.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDMQAradigmN/ANDRAENDRA Life Sciences1.19%TTOOT2 Biosystems23.18%VTAKCatheter Precision20.34%Insider OwnershipCompanyInsider OwnershipARDMQAradigm4.50%NDRAENDRA Life Sciences0.04%TTOOT2 Biosystems0.03%VTAKCatheter Precision2.95%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDMQAradigm2315.28 millionN/ANot OptionableNDRAENDRA Life Sciences20740,000738,000Not OptionableTTOOT2 Biosystems18021.04 million21.04 millionOptionableVTAKCatheter Precision1411.02 million10.69 millionN/AARDMQ, TTOO, VTAK, and NDRA HeadlinesRecent News About These CompaniesCatheter Precision, Inc. Announces First Purchase Order From University Hospital in Rennes, FranceJuly 7 at 6:21 PM | finance.yahoo.comCatheter Precision, Inc. and Chelak iECG, Inc. Launch Joint Venture Kardionav for Advancements in Ventricular Tachycardia Ablation Technology - NasdaqJuly 2, 2025 | nasdaq.comCatheter Precision, Inc. Forms new Joint Venture Called Kardionav to Exploit patented AI Techniques to Create New VT Software platformJune 30, 2025 | finance.yahoo.comCatheter Precision, Inc. and Chelak iECG, Inc. Launch Joint Venture Kardionav for Advancements in Ventricular Tachycardia Ablation TechnologyJune 30, 2025 | quiverquant.comQCatheter Precision Inc News (VTAK) - Investing.comJune 28, 2025 | investing.comCatheter Precision, Inc. Addresses Increased Trading Activity in Common StockJune 12, 2025 | quiverquant.comQCatheter Precision, Inc. Comments on Recent Market ActivityJune 12, 2025 | globenewswire.comCatheter Precision (VTAK) Reports Key Progress for the LockeT ProductJune 12, 2025 | finance.yahoo.comCatheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University HospitalJune 9, 2025 | finance.yahoo.comCatheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital | ...June 9, 2025 | gurufocus.comCatheter Precision, Inc. Secures First Order for VIVO Product from Sahlgrenska University Hospital in SwedenJune 9, 2025 | quiverquant.comQCatheter Precision, Inc. Receives CE Mark Approval for LockeT, Expanding Market Opportunities in EuropeMay 27, 2025 | quiverquant.comQCatheter Precision, Inc. Receives CE Mark for LockeTMay 27, 2025 | globenewswire.comCatheter Precision Enters Market Offering AgreementMay 19, 2025 | tipranks.comCatheter Precision, Inc. Announces First Quarter 2025 Update and Financial ResultsMay 15, 2025 | finance.yahoo.comCatheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and ...May 12, 2025 | gurufocus.comCatheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic AllianceMay 12, 2025 | globenewswire.comCatheter Precision Finalizes Strategic Cardiac AcquisitionMay 8, 2025 | tipranks.comCatheter Precision, Inc. Completes Acquisition of Cardionomic Heart Failure AssetsMay 6, 2025 | finance.yahoo.comNew Clinical Data Presented about VIVO at the 46th Annual Heart Rhythm Association ConferenceMay 1, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeARDMQ, TTOO, VTAK, and NDRA Company DescriptionsAradigm OTCMKTS:ARDMQ$0.05 0.00 (0.00%) As of 06/30/2020Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung.ENDRA Life Sciences NASDAQ:NDRA$8.84 +0.54 (+6.51%) Closing price 04:00 PM EasternExtended Trading$8.97 +0.13 (+1.47%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.T2 Biosystems NASDAQ:TTOO$0.13 -0.01 (-5.78%) As of 03:32 PM EasternT2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.Catheter Precision NYSEAMERICAN:VTAK$0.24 -0.01 (-3.40%) Closing price 04:10 PM EasternExtended Trading$0.24 0.00 (0.00%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Why Marvell Could Be the Smartest AI Bet Under $80 Autodesk Stock Ready to Rip? Q3 May Be the Turning Point Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
